Ivermectin in veterinary medicine: a narrative review of antiparasitic efficacy, resistance evolution, antiviral evidence, and One Health implications. [PDF]
Halma MTJ +4 more
europepmc +1 more source
Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells. [PDF]
Kim J +7 more
europepmc +1 more source
Genetic selection by ivermectin on Onchocerca volvulus
Onchocerca volvulus is a parasitic filarial nematode responsible for human onchocerciasis, a disease commonly known as "River Blindness". Although there are no well documented cases of ivermectin resistance in O. volvulus, reports of suboptimal responses
Eng, Jeffrey K. L.
core
Development and characterization of ivermectin nanoformulations for topical acaricidal activity against Rhipicephalus sanguineus ticks. [PDF]
Abdel-Ghany HSM +3 more
europepmc +1 more source
Interactive effects of ivermectin and nitrogen levels on phytoplankton biomass and stress responses. [PDF]
Dauda S +8 more
europepmc +1 more source
Background. Scabies and impetigo cause direct health effects and contribute to severe infectious and immune-mediated complications. Ivermectin-based mass drug administration can reduce scabies and impetigo prevalence in island settings with high ...
Steer, Andrew C +9 more
core +1 more source
Integrated in vitro and in vivo evaluation of ivermectin hydrogel formulation for management of scabies with pharmacological assessment. [PDF]
Mohamed SA +10 more
europepmc +1 more source
Ivermectin therapy is associated with changes in SARS-CoV-2 RNA load in asymptomatic patients: a randomized controlled trial. [PDF]
Mouawia H +7 more
europepmc +1 more source
Ivermectin Bezoar: An Unusual Case Presentation. [PDF]
Miller SM +3 more
europepmc +1 more source
Selection of the optimal long-acting injectable formulation of ivermectin for use in humans to target malaria vectors in Western Africa: evaluation of pharmacokinetics and mosquitocidal efficacy in cattle under laboratory conditions. [PDF]
Zela L +14 more
europepmc +1 more source

